Janssen Pharmaceuticals, Inc.
Recent News About Janssen Pharmaceuticals, Inc.
-
Oklahoma judge feeds the 'monster' with $572M opioid ruling against Johnson & Johnson
Sixteen years ago in a case involving gunmaker Sturm, Ruger & Co., a New York appeals court refused to apply public nuisance law against the manufacturer of a legal product, saying that doing so would transform nuisance law “into a monster that would devour in one gulp the entire law of tort.” -
Private lawyers stand to make $90 million as judge hits Johnson & Johnson with $572M opioid ruling
NORMAN, Okla. (Legal Newsline) - A state judge in Oklahoma has blamed Johnson & Johnson for the state's opioid crisis and ordered it to pay $572 million in damages, extending public nuisance law beyond its traditional boundaries into what may become an all-purpose tool for government lawsuits against product manufacturers. -
First Xarelto federal bellwether trial beginning in Louisiana court
NEW ORLEANS – The initial bellwether trial to ascertain whether the manufacturers of Xarelto are liable for claims which allege the blood-thinning medication caused injury or death to more than 15,000 patients was slated to begin Monday in a Louisiana federal court.